熱門資訊> 正文
Crescent Capital BCD 2025年第二季度盈利预览
2025-08-13 05:35
- Crescent Capital BDC (NASDAQ:CCAP) is scheduled to announce Q2 earnings results on Wednesday, August 13th, after market close.
- The consensus EPS Estimate is $0.47 and the consensus Revenue Estimate is $42.52M.
- Over the last 1 year, CCAP has beaten EPS estimates 75% of the time and has beaten revenue estimates 50% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 6 downward. Revenue estimates have seen 0 upward revisions and 5 downward.
More on Crescent Capital BDC
- Crescent Capital BDC: Unfairly Discounted With Income
- Crescent Capital: 11% Yield And Fire Sale Price Make It A Buy
- Crescent Capital BDC: NAV Decline Continues Following Q1 Earnings
- Crescent Capital BDC signals stable dividend and portfolio resilience while navigating non-accrual uptick
- Crescent Capital BDC declares $0.42 dividend
推薦文章
一周財經日曆丨降息信號將定？下周全球央行年會成關鍵；小米、泡泡瑪特、快手領銜港股財報潮
港股周報丨見證歷史！南向資金單日瘋狂買入港股359億港元；騰訊績后股價一度升破600港元
特朗普政府據悉考慮動用芯片法案資金來入股英特爾
美股機會日報丨「恐怖數據」符合預期，交易員下調美聯儲降息預期；巴菲特Q2新建倉股飆升，聯合健康盤前漲超10%
銀諾醫藥-B上市首日暴漲285%，一手賺超1萬港元
投資大佬Tepper減持阿里巴巴、京東等 買入股價暴跌的聯合健康
伯克希爾減持蘋果股份 增持聯合健康集團
8月15日外盤頭條：特朗普政府洽購英特爾股份 貝森特否認推動降息 蘋果重新設計Apple Watch血氧功能
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
